Advisory Board November 13, 2024

Although the side effects of GLP-1 drugs, which are used for diabetes and weight loss, are typically mild, some patients have reported more severe issues, including stomach paralysis and gallbladder damage. As more reports of severe GLP-1 side effects emerge, thousands of patients are filing lawsuits against GLP-1 manufacturers.

Resource library: Weight management and obesity care

GLP-1 manufacturers face dozens of lawsuits

GLP-1 drugs, which are used to treat diabetes and weight loss, have surged in popularity in recent years, with data showing that 40 times more GLP-1 prescriptions were written in 2023 compared to 2018. Two major manufacturers of the drugs are Novo Nordisk, which makes Ozempic, Wegovy, and Rybelsus, and Eli Lilly, which makes Trulicity, Mounjaro, and Zepbound.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected
NIH's unfinished business
Lilly blames slower-than-expected growth for 2024 sales miss
AbbVie to write off $3.5B over failed schizophrenia drug

Share This Article